Variant report
Variant | esv3440380 |
---|---|
Chromosome Location | chr21:46800052-46800593 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOSL2 | chr21:46800056-46800534 | HepG2 | liver: | n/a | n/a |
2 | MYC | chr21:46800003-46800060 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | MYC | chr21:46800049-46800119 | MCF-7 | breast: | n/a | n/a |
4 | NR3C1 | chr21:46800032-46800489 | A549 | lung: | n/a | n/a |
5 | NR3C1 | chr21:46799906-46800539 | A549 | lung: | n/a | n/a |
6 | NR3C1 | chr21:46800027-46800421 | A549 | lung: | n/a | n/a |
7 | PAX5 | chr21:46800040-46800529 | GM12878 | blood: | n/a | n/a |
8 | POLR2A | chr21:46800577-46800785 | MCF-7 | breast: | n/a | n/a |
9 | POLR2A | chr21:46800006-46800054 | MCF-7 | breast: | n/a | n/a |
10 | POLR2A | chr21:46799926-46800172 | MCF-7 | breast: | n/a | n/a |
11 | POU2F2 | chr21:46800008-46800561 | GM12878 | blood: | n/a | n/a |
12 | REST | chr21:46799984-46800557 | PANC-1 | pancreas: | n/a | n/a |
13 | TCF3 | chr21:46799948-46800560 | GM12878 | blood: | n/a | n/a |
14 | ZBTB33 | chr21:46800062-46800461 | K562 | blood: | n/a | n/a |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr21:46743301..46745333-chr21:46800514..46802613,2 | MCF-7 | breast: | |
2 | chr21:46711095..46714807-chr21:46800343..46802512,3 | MCF-7 | breast: | |
3 | chr21:46786827..46788871-chr21:46799843..46802359,2 | MCF-7 | breast: | |
4 | chr21:46737653..46759617-chr21:46790778..46832239,260 | MCF-7 | breast: | |
5 | chr21:46435738..46437845-chr21:46799987..46802608,2 | K562 | blood: | |
6 | chr21:46783218..46786077-chr21:46800000..46803414,3 | MCF-7 | breast: | |
7 | chr21:46800012..46801614-chr21:46802538..46805241,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
MTCO1P3 | TF binding region |
ENSG00000228355 | TF binding region |
ENSG00000229382 | chromatin interactions |
ENSG00000223768 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528292616 | chr21:46800072-46800073 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
2 | rs146999746 | chr21:46800110-46800111 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs9680392 | chr21:46800113-46800114 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs59793661 | chr21:46800118-46800119 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs112339807 | chr21:46800123-46800124 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs182071332 | chr21:46800127-46800128 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs116661345 | chr21:46800137-46800138 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs56908540 | chr21:46800158-46800159 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs569997810 | chr21:46800163-46800164 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs35523386 | chr21:46800179-46800180 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs537082791 | chr21:46800185-46800186 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs34662688 | chr21:46800191-46800192 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs59983800 | chr21:46800229-46800230 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs60892227 | chr21:46800235-46800236 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs374267256 | chr21:46800242-46800243 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs555806411 | chr21:46800244-46800245 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs61496146 | chr21:46800245-46800246 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs34412205 | chr21:46800257-46800258 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs59820042 | chr21:46800267-46800268 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs370197619 | chr21:46800274-46800275 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs35871257 | chr21:46800279-46800280 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs550566137 | chr21:46800280-46800281 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
23 | rs34625028 | chr21:46800310-46800311 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
24 | rs35839579 | chr21:46800314-46800315 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs368468769 | chr21:46800325-46800326 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs534581186 | chr21:46800332-46800333 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs371949892 | chr21:46800337-46800338 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs10552002 | chr21:46800344-46800345 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
29 | rs35156193 | chr21:46800349-46800350 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
30 | rs62216264 | chr21:46800384-46800385 | Weak transcription Enhancers Genic enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
31 | rs541215636 | chr21:46800404-46800405 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
32 | rs372944987 | chr21:46800451-46800452 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
33 | rs376463479 | chr21:46800452-46800453 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
34 | rs57700331 | chr21:46800456-46800457 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
35 | rs577817861 | chr21:46800465-46800466 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
36 | rs200481562 | chr21:46800485-46800486 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
37 | rs545263230 | chr21:46800490-46800491 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
38 | rs563862800 | chr21:46800495-46800496 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
39 | rs142377578 | chr21:46800499-46800500 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
40 | rs111657382 | chr21:46800501-46800502 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
41 | rs542305025 | chr21:46800503-46800504 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
42 | rs113600242 | chr21:46800509-46800510 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
43 | rs112785506 | chr21:46800512-46800513 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
44 | rs561032771 | chr21:46800560-46800561 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
45 | rs533241101 | chr21:46800562-46800563 | ZNF genes & repeats Enhancers Weak transcription Genic enhancers Bivalent/Poised TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Mental retardation | 21031080 | CNVD |
Polymicrogyria | 21031080 | CNVD |
periventricular nodular heterotopia | 21031080 | CNVD |
Myelodysplastic syndrome | 21606161 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Autism | 18414403 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17899364 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 20473283 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 23341502 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Cholangiocarcinoma | 16830362 | CNVD |
Down syndrome | 17334655 | CNVD |
Neuroticism | 17667963 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Autoimmune polyendocrine syndrome | 18200029 | CNVD |
Prostate cancer | 19363497 | CNVD |
Lung cancer | 17086460 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Multiple myeloma | 16616336 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17142309 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Lung cancer | 21203850 | CNVD |
Ependymoma | 20639864 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:46787600-46806800 | Weak transcription | Right Atrium | heart |
2 | chr21:46793400-46806400 | Weak transcription | Esophagus | oesophagus |
3 | chr21:46798200-46807600 | Weak transcription | H9 Cell Line | embryonic stem cell |
4 | chr21:46798400-46800200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr21:46798400-46800200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr21:46798600-46800800 | Enhancers | Pancreas | Pancrea |
7 | chr21:46798800-46800400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr21:46798800-46800400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr21:46799600-46803400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
10 | chr21:46799800-46800200 | Genic enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr21:46799800-46803600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
12 | chr21:46800000-46800800 | Enhancers | Right Ventricle | heart |
13 | chr21:46800000-46801000 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr21:46800200-46801200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr21:46800200-46803200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr21:46800200-46805200 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
17 | chr21:46800400-46800600 | Bivalent/Poised TSS | Foreskin Melanocyte Primary Cells skin01 | Skin |
18 | chr21:46800400-46800800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |